•  
  •  
  •  
  •  

2025-12-23 10:36:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  INE883N01014

Stock Report

  • Parag Milk Foods Ltd. strengthens Board with appointment of Independent Directors
  • Parag Milk Foods Limited recommends final dividend of Rs. 1
  • Ace Investor, Mr. Utpal Sheth Invests in Parag Milk Foods
  • Parag Milk Foods Limited Raises ₹161 Crore
  • Parag Milk Foods Strengthens Leadership Commitment with Convertible Warrants Allotment to CSO Mr. Ankit Jain
  • Parag Milk Foods strengthens its products portfolio with High-Protein, Nutrient-Rich Offerings
  • Parag Milk Foods appoints Ex-Lactalis India & Amul MD, Mr. Rahul Kumar Srivastava as COO
  • Krishnamurthy Suryanarayan appointed as CFO of Parag Milk Foods Ltd
  • Parag Milk Foods Ltd raises Rs. 131 Crores through preferential allotment
  • Gowardhan Ghee launches a New Winter Campaign - 'Thand Padi'
  • Parag Milk Foods Ltd's application under PLI scheme approved
  • Parag Milk Foods Limited updates on IT search

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024